[25-NSE] Vaxart, Inc. SEC Filing

Rhea-AI Filing Summary

Vaxart, Inc. (VXRT) has had its common stock removed from listing and/or registration on the Nasdaq Stock Market LLC. Nasdaq filed Form 25 under Section 12(b) of the Securities Exchange Act of 1934, stating that it has complied with its rules to strike this class of securities from listing and withdraw its registration on the exchange. The filing specifies that the action concerns Vaxart’s common stock, which means the shares will no longer be listed for trading on Nasdaq.

Positive

• None.

Negative

• Vaxart’s common stock has been removed from listing and/or registration on the Nasdaq Stock Market LLC under Section 12(b).

Insights

Equity markets & listings analyst

Vaxart common stock has been removed from Nasdaq listing, a negative development.

The filing shows that Vaxart, Inc. (VXRT) common stock is being removed from listing and/or registration on the Nasdaq Stock Market LLC via Form 25 under Section 12(b) of the Exchange Act. This means the stock will no longer trade on Nasdaq, shifting it to a less prominent trading venue or over-the-counter markets depending on subsequent steps.

Loss of a major exchange listing typically reduces liquidity and may widen trading spreads, which can affect how easily shareholders can buy or sell shares. The document does not provide reasons or financial details for the delisting; it focuses on Nasdaq certifying compliance with its rules and the relevant SEC regulations.

For investors, the key fact is the change in trading venue for Vaxart’s common stock following Nasdaq’s Form 25. Subsequent company communications and future filings would be the place to find more detail on trading arrangements and any strategic or financial context around this delisting.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-35285

Issuer:	Vaxart, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	290 Utah Ave, Suite 200
	South San Francisco	CALIFORNIA	94080
Telephone number:					650-550-3500

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-11-21	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Vaxart’s (VXRT) Form 25 filing mean?

The Form 25 states that Vaxart, Inc. common stock is being removed from listing and/or registration on the Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act.

Which Vaxart (VXRT) security is affected by this Form 25?

The filing applies to Vaxart’s common stock, which is the class of securities identified for removal from listing and/or registration on Nasdaq.

Who initiated the delisting of Vaxart (VXRT) common stock?

The notification is filed by the Nasdaq Stock Market LLC, which certifies that it has complied with its rules to strike Vaxart’s common stock from listing and withdraw its registration on the exchange.

Under which regulations is Vaxart (VXRT) being delisted from Nasdaq?

The action is taken under Section 12(b) of the Securities Exchange Act of 1934 and the related rules, including 17 CFR 240.12d2-2 provisions referenced in the form.

What is the Commission File Number for Vaxart’s (VXRT) Form 25?

The Form 25 for Vaxart’s common stock removal from Nasdaq lists Commission File Number 001-35285.

Does the Form 25 explain why Vaxart (VXRT) was delisted?

The content indicates that Nasdaq has complied with its rules and applicable regulations to remove Vaxart’s common stock from listing and registration, but it does not state specific reasons for the delisting.